Trade Secrets: intellectual property in the pharmaceutical industry

Professor of economics at the department of economics and business at Colorado College and senior fellow at the Fraser Institute, Kristina Acri, joins me this week to discuss pharmaceutical economics and the role intellectual property plays in the pharmaceutical industry. We even get into the pros and cons of pharmaceutical IP, both in the long and short-term.

[gopaulbassmusic]

The free market view that innovators are looking at are abroad. There is no way that an individual that comes up with a product that is innovative would survive the dog eat dog world of the USA. The question that I was wondering and led me to your video is : How would one actually be able to keep the list of ingredients out of circulation because you have to get it approved. Who is to say that the individuals with the review board won't sell it across the pond?

[ghoulape]

So pretty much, they force you to pay more then you can afford. For no other reason but to hurt your pockets.